Crohn's & Colitis Foundation and AGA announce conference partnership

The Crohn's & Colitis Foundation and the American Gastroenterological Association (AGA) announced today that they are partnering to co-sponsor the first-ever "Crohn's & Colitis Congress," which will take place in Las Vegas in January 2018.

The Crohn's & Colitis Congress will be the premier conference for inflammatory bowel diseases (IBD) health-care professionals and researchers. It will bring state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.

"We are thrilled to be partnering with AGA, the nation's premier gastroenterological professional organization on this new conference," said Michael Osso, President & CEO of the Foundation. "By working together, we will bridge the patient and professional perspectives, and create a multidisciplinary, clinically-focused and forward-thinking experience for all attendees."

The new conference will focus on a comprehensive, patient-centered approach to IBD care, with sessions addressing the current realities and challenges in the disease space. The most advanced, cutting-edge research will be presented to assist the IBD community in providing the best quality of care to the 1.6 million Americans living with these diseases.

"We are proud to be part of the Crohn's & Colitis Foundation's work to cure Crohn's disease and ulcerative colitis," said Tom Serena, executive vice president of AGA. "The Crohn's & Colitis Congress will be 2018's must-attend meeting for scientists and clinicians who want to accelerate advances in IBD patient care."

To plan the conference agenda, staff from the Foundation and AGA will work with an organizing committee comprised of leading health-care professionals representing the key disciplines involved in the comprehensive care of IBD as well as research.

Provided by American Gastroenterological Association